Trials / Completed
CompletedNCT02849262
Pharmacodynamics, Safety and Efficacy of Topical Omiganan in Patients With External Genital Warts
A Phase 2, Randomized, Vehicle-Controlled, Double-Blind, Parallel-Group Study to Explore the Pharmacodynamics, Safety and Efficacy of Topical Omiganan in Patients With External Genital Warts
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Maruho Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess the pharmacodynamics, safety and efficacy of omiganan in patients with external genital warts.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Omiganan (CLS001) topical gel | |
| DRUG | Vehicle topical gel |
Timeline
- Start date
- 2016-07-01
- Primary completion
- 2017-03-21
- Completion
- 2017-03-21
- First posted
- 2016-07-29
- Last updated
- 2017-03-31
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT02849262. Inclusion in this directory is not an endorsement.